HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Related articles in AJPH Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Janerich, D T Articles by Polednak, A P Search for Related Content PubMed PubMed Citation Articles by Janerich, D T Articles by Polednak, A P

The screening histories of women with invasive cervical cancer, Connecticut.

D T Janerich, O Hadjimichael, P E Schwartz, D M Lowell, J W Meigs, M J Merino, J T Flannery and A P Polednak

Department of Medicine, University of Utah School of Medicine, Salt Lake City 84132, USA.

OBJECTIVES. Each case of a continuous series of invasive cervical cancer cases was studied with a structured review procedure conducted by an expert panel to assess the reason that it was not detected before it became invasive. METHODS. All cases of invasive cervical cancer diagnosed in a 5-year period among Connecticut residents were identified; a screening history and screening outcome were obtained for 72% (481 of 664). RESULTS. Two hundred fifty women (51.9%) had suboptimal screening. One hundred thirty-seven women (28.5%) had never had a screening test, and their mean age was greater than that of the rest of the study population (64.5 years vs 46.5 years). Of the 344 women who had ever had a Pap test, 113 (32.8%) had their last Pap test 5 or more years before their diagnosis of invasive cancer; 52 (15.1%) were not followed up properly; 33 (9.6%) had their last smear misread as normal; and 118 (34.3%) developed cervical cancer within 3 years of their last Pap test. CONCLUSIONS. Physicians, nurses, and other care providers need to ensure that woman have timely and accurate screening with proper follow-up, make increased efforts to reach older women, and improve quality control of Pap smear readings.

Related articles in AJPH:

Surveillance for pesticide-related illness--lessons from California.

D C Ordin and L J Fine
AJPH 1995 85: 762-763. [PDF]  

This article has been cited by other articles:

				K. S. Eggleston, A. L. Coker, K. J. Luchok, and T. E. Meyer Adherence to Recommendations for Follow-up to Abnormal Pap Tests Obstet. Gynecol., June 1, 2007; 109(6): 1332 - 1341. [Abstract] [Full Text] [PDF]

				A. Herbert and J. H F Smith Women under 25 should be offered screening BMJ, February 10, 2007; 334(7588): 273 - 273. [Full Text] [PDF]

				W. A. Leyden, M. M. Manos, A. M. Geiger, S. Weinmann, J. Mouchawar, K. Bischoff, M. U. Yood, J. Gilbert, and S. H. Taplin Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process J Natl Cancer Inst, May 4, 2005; 97(9): 675 - 683. [Abstract] [Full Text] [PDF]

				C. R. Breitkopf, J. Catero, J. Jaccard, and A. B. Berenson Psychological and Sociocultural Perspectives on Follow-up of Abnormal Papanicolaou Results Obstet. Gynecol., December 1, 2004; 104(6): 1347 - 1354. [Abstract] [Full Text] [PDF]

				K. Behbakht, A. Lynch, S. Teal, K. Degeest, and S. Massad Social and Cultural Barriers to Papanicolaou Test Screening in an Urban Population Obstet. Gynecol., December 1, 2004; 104(6): 1355 - 1361. [Abstract] [Full Text] [PDF]

				M Garipagaoglu, F Kayikcioglu, M F Kose, M Adli, K H Gulkesen, Z Kocak, and G Tulunay Adding concurrent low dose continuous infusion of cisplatin to radiotherapy in locally advanced cervical carcinoma: a prospective randomized pilot study Br. J. Radiol., July 1, 2004; 77(919): 581 - 587. [Abstract] [Full Text] [PDF]

				C. L. Trimble, L. A. Richards, B. Wilgus-Wegweiser, K. Plowden, D. L. Rosenthal, and A. Klassen Effectiveness of Screening for Cervical Cancer in an Inpatient Hospital Setting Obstet. Gynecol., February 1, 2004; 103(2): 310 - 316. [Abstract] [Full Text] [PDF]

				P. W. Rufleth, G. F. Sawaya, S. Kulasingam, and H. Lawson Extending the Interval between Cervical-Cancer Screenings N. Engl. J. Med., January 22, 2004; 350(4): 414 - 415. [Full Text] [PDF]

				G. F. Sawaya, K. J. McConnell, S. L. Kulasingam, H. W. Lawson, K. Kerlikowske, J. Melnikow, N. C. Lee, G. Gildengorin, E. R. Myers, and A. E. Washington Risk of Cervical Cancer Associated with Extending the Interval between Cervical-Cancer Screenings N. Engl. J. Med., October 16, 2003; 349(16): 1501 - 1509. [Abstract] [Full Text] [PDF]

				A.-M. E. Amies, L. Miller, S.-K. Lee, and L. Koutsky The Effect of Vaginal Speculum Lubrication on the Rate of Unsatisfactory Cervical Cytology Diagnosis Obstet. Gynecol., November 1, 2002; 100(5): 889 - 892. [Abstract] [Full Text] [PDF]

				A. R. Giuliano, M. Papenfuss, M. Abrahamsen, C. Denman, J. G. de Zapien, J. L. N. Henze, L. Ortega, E. M. B. de Galaz, J. Stephan, J. Feng, et al. Human Papillomavirus Infection at the United States-Mexico Border: Implications for Cervical Cancer Prevention and Control Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1129 - 1136. [Abstract] [Full Text] [PDF]

				G. F. Sawaya, A. D. Brown, A. E. Washington, and A. M. Garber Current Approaches to Cervical-Cancer Screening N. Engl. J. Med., May 24, 2001; 344(21): 1603 - 1607. [Full Text] [PDF]

				T. C. Wright Jr, L. Denny, L. Kuhn, A. Pollack, and A. Lorincz HPV DNA Testing of Self-collected Vaginal Samples Compared With Cytologic Screening to Detect Cervical Cancer JAMA, January 5, 2000; 283(1): 81 - 86. [Abstract] [Full Text] [PDF]

				R. A. Hiatt and B. K. Rimer A New Strategy for Cancer Control Research Cancer Epidemiol. Biomarkers Prev., November 1, 1999; 8(11): 957 - 964. [Full Text]

				G. F. Sawaya and D. A. Grimes NEW TECHNOLOGIES IN CERVICAL CYTOLOGY SCREENING: A WORD OF CAUTION Obstet. Gynecol., August 1, 1999; 94(2): 307 - 310. [Abstract] [Full Text] [PDF]

				P. G. Rose, B. N. Bundy, E. B. Watkins, J. T. Thigpen, G. Deppe, M. A. Maiman, D. L. Clarke-Pearson, and S. Insalaco Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer N. Engl. J. Med., April 15, 1999; 340(15): 1144 - 1153. [Abstract] [Full Text] [PDF]

				M. D. Greenberg, L. G. Koss, L. J. Mango, P. W. Radensky, C. B. Schechter, T. J. O'Leary, S.-B. Buckner, C. W. Ollayos, and A. M. Garber Rescreening of Cervical Papanicolaou Smears Using PAPNET JAMA, June 10, 1998; 279(22): 1785 - 1788. [Full Text] [PDF]

				V. B. Benard, C. R. Eheman, H. W. Lawson, D. K. Blackman, C. Anderson, W. Helsel, S. F. Thames, and N. C. Lee Cervical Screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001 Obstet. Gynecol., January 1, 1992; 103(3): 564 - 571. [Abstract] [Full Text]